Jordan Pomeroy, MD, PhD

Start Year
2016

Education and Training

Medical School
Keck School of Medicine of the University of Southern California

Residency
Duke

Career and research goals

I am currently part of the Clinician Investigator Pathway (CIP) in the Division of Cardiology in the Department of Medicine at Duke. I plan on being a leader in the field of cardiac regeneration with particular focus on the fidelity of the electrical system during regeneration. The CIP program has provided me with 3 years of protected research time to establish myself as a fully-funded, independent clinician investigator upon completion of my clinical cardiology fellowship in 2021. I am excited to see the development of regenerative technologies for cardiac disease and ready to translate this success to patient care.

Honors, awards and distinctions

  • Eagle Scout
  • Alpha Omega Alpha

About me

I completed a combined MD, PhD program at USC with my PhD work in the lab of Dr. Martin F Pera. We focused on characterizing pluripotency in human pluripotent stem cells (hPSCs). This research has laid the foundation for my future interests in cardiac regenerative medicine.

My wife, Summer, and I enjoy living in the Triangle with the vast food and outdoor offerings. Summer coaches girls lacrosse with Carolina Fever and Carolina Blast club teams.

 

Publications

Pomeroy, JE, Nguyen, HX, Hoffman, BD, and Bursac, N. "Genetically Encoded Photoactuators and Photosensors for Characterization and Manipulation of Pluripotent Stem Cells." Theranostics 7, no. 14 (January 2017): 3539-3558. (Review)

PMID
28912894
Full Text

Pomeroy, JE, Hough, SR, Davidson, KC, Quaas, AM, Rees, JA, and Pera, MF. "Stem Cell Surface Marker Expression Defines Late Stages of Reprogramming to Pluripotency in Human Fibroblasts." STEM CELLS Translational Medicine 5, no. 7 (July 2016): 870-882.

Full Text

Hasegawa, K, Zhang, P, Wei, Z, Pomeroy, JE, Lu, W, and Pera, MF. "Comparison of Reprogramming Efficiency Between Transduction of Reprogramming Factors, Cell-Cell Fusion, and Cytoplast Fusion." STEM CELLS 28, no. 8 (August 2010): 1338-1348.

Full Text

Hasegawa, K, Pomeroy, JE, and Pera, MF. "Current Technology for the Derivation of Pluripotent Stem Cell Lines from Human Embryos." Cell Stem Cell 6, no. 6 (June 2010): 521-531.

Full Text

Schwarz, DA, Allen, MM, Petroski, RE, Pomeroy, JE, Heise, CE, Mistry, MS, Selkirk, JV, Nottebaum, LM, Grey, J, Zhang, M, Goodfellow, VS, and Maki, RA. "Manipulation of small-molecule inhibitory kinetics modulates MCH-R1 function." Molecular and Cellular Endocrinology 259, no. 1-2 (October 2006): 1-9.

Full Text

Petroski, RE. "Indiplon Is a High-Affinity Positive Allosteric Modulator with Selectivity for  1 Subunit-Containing GABAA Receptors." Journal of Pharmacology and Experimental Therapeutics 317, no. 1 (December 21, 2005): 369-377.

Full Text

Selkirk, JV, Nottebaum, LM, Vana, AM, Verge, GM, Mackay, KB, Stiefel, TH, Naeve, GS, Pomeroy, JE, Petroski, RE, Moyer, J, Dunlop, J, and Foster, AC. "Role of the GLT-1 subtype of glutamate transporter in glutamate homeostasis: the GLT-1-preferring inhibitor WAY-855 produces marginal neurotoxicity in the rat hippocampus." European Journal of Neuroscience 21, no. 12 (June 2005): 3217-3228.

Full Text

Amores, A. "Developmental Roles of Pufferfish Hox Clusters and Genome Evolution in Ray-Fin Fish." Genome Research 14, no. 1 (December 12, 2003): 1-10.

Full Text